Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
tc2000chartreader's Profile
Displaying 1-50 of 2878 result(s).
GNBTQ Generex Biotechnology Corp.
03/05/2021 12:30:11 PM
Was watching MSNBC this morning and (4)
GNBTQ Generex Biotechnology Corp.
03/05/2021 12:27:35 PM
Looking at those transactions, ever (2)
GNBTQ Generex Biotechnology Corp.
03/04/2021 3:29:47 PM
doc, that was a little TOO graphic. (1)
GNBTQ Generex Biotechnology Corp.
03/04/2021 12:52:34 PM
Full Disclosure, I bought just a fe (4)
GNBTQ Generex Biotechnology Corp.
03/04/2021 12:10:33 PM
Very true, 3 S1s were filed with FI (6)
GNBTQ Generex Biotechnology Corp.
03/04/2021 11:42:08 AM
You are right buildit, NGIO IPO is (9)
GNBTQ Generex Biotechnology Corp.
01/10/2021 6:31:51 PM
True doc, but we haven’t been tol
GNBTQ Generex Biotechnology Corp.
01/10/2021 5:38:33 PM
https://www.investopedia.com/ask/a (1)
GNBTQ Generex Biotechnology Corp.
01/10/2021 5:35:48 PM
Forgot all about the preferred shar
GNBTQ Generex Biotechnology Corp.
01/10/2021 5:34:12 PM
You are comparing an unknown NGIO v
GNBTQ Generex Biotechnology Corp.
01/10/2021 4:19:31 PM
Actually I can’t imagine the mark (1)
GNBTQ Generex Biotechnology Corp.
01/10/2021 1:37:37 PM
I guess after NGIO gets listed. GNB (2)
GNBTQ Generex Biotechnology Corp.
01/09/2021 6:37:29 PM
About 9.1% of the 400.300,000 so 36 (1)
GNBTQ Generex Biotechnology Corp.
01/09/2021 10:29:33 AM
I don’t agree with this. I think (6)
GNBTQ Generex Biotechnology Corp.
01/09/2021 10:16:12 AM
Wow, never considered a reverse spl (2)
GNBTQ Generex Biotechnology Corp.
01/08/2021 5:22:58 PM
This sounds positive... “ This th (4)
GNBTQ Generex Biotechnology Corp.
01/08/2021 5:21:35 PM
2/5 conf call at 9AM, sorry rjs htt (1)
GNBTQ Generex Biotechnology Corp.
01/08/2021 5:19:33 PM
If we can sell...lol. Seriously, we (2)
GNBTQ Generex Biotechnology Corp.
01/08/2021 3:55:59 PM
Well remember, any company is only (2)
GNBTQ Generex Biotechnology Corp.
01/08/2021 3:51:01 PM
I always thought 400M shares was wa (2)
GNBTQ Generex Biotechnology Corp.
01/08/2021 3:14:04 PM
This is a disappointing valuation. (2)
GNBTQ Generex Biotechnology Corp.
01/07/2021 2:00:41 PM
I don't have a direct line to ask J (2)
GNBTQ Generex Biotechnology Corp.
01/07/2021 1:19:44 PM
hylander, your logic is wrong...lol
GNBTQ Generex Biotechnology Corp.
01/07/2021 1:16:32 PM
Not saying that is how it should be (1)
GNBTQ Generex Biotechnology Corp.
01/07/2021 12:47:10 PM
I believe rjs tried to answer this (1)
GNBTQ Generex Biotechnology Corp.
01/07/2021 12:43:27 PM
Buildit, that is a very good point. (2)
GNBTQ Generex Biotechnology Corp.
01/07/2021 12:21:53 PM
Don't think we will see an 8K. They (1)
GNBTQ Generex Biotechnology Corp.
01/07/2021 11:58:17 AM
OT... specifically one in a 'costum (5)
GNBTQ Generex Biotechnology Corp.
01/06/2021 2:03:10 PM
I think you are reaching for straws (2)
GNBTQ Generex Biotechnology Corp.
01/06/2021 1:23:50 PM
While that would be a great idea, s
GNBTQ Generex Biotechnology Corp.
01/05/2021 9:29:34 PM
So that brings up the point, that s (4)
GNBTQ Generex Biotechnology Corp.
01/05/2021 8:29:29 PM
My suggestion was why did they give (2)
GNBTQ Generex Biotechnology Corp.
01/05/2021 3:39:20 PM
It’s more interesting that GNBT r (2)
GNBTQ Generex Biotechnology Corp.
01/04/2021 6:35:48 PM
Exactly. Incentives are there to en (1)
GNBTQ Generex Biotechnology Corp.
01/04/2021 4:08:18 PM
I agree Cody. However human tendenc (2)
GNBTQ Generex Biotechnology Corp.
01/04/2021 3:16:47 PM
Well, for 1 thing, they are on the (3)
GNBTQ Generex Biotechnology Corp.
01/04/2021 2:18:31 PM
Bonus shares are usually locked up (1)
GNBTQ Generex Biotechnology Corp.
01/04/2021 2:11:10 PM
Would be interesting to know where (5)
GNBTQ Generex Biotechnology Corp.
01/04/2021 2:06:35 PM
Let's hope the share bonus will be (2)
GNBTQ Generex Biotechnology Corp.
12/29/2020 6:49:48 PM
Just checked my 12/2019 statement a (2)
GNBTQ Generex Biotechnology Corp.
12/29/2020 6:38:25 PM
You are probably right. Most system (1)
GNBTQ Generex Biotechnology Corp.
12/29/2020 4:13:25 PM
12/31/2019 closing price $0.4429. N
GNBTQ Generex Biotechnology Corp.
12/29/2020 4:01:54 PM
exactly doc. 9%/day would double yo (1)
GNBTQ Generex Biotechnology Corp.
12/29/2020 3:54:13 PM
Over 1M shares trading today at the (2)
GNBTQ Generex Biotechnology Corp.
12/28/2020 12:53:22 PM
Huge increase in warrants, which cu
GNBTQ Generex Biotechnology Corp.
12/17/2020 9:01:43 PM
Well tomato tomato, you know what I
GNBTQ Generex Biotechnology Corp.
12/17/2020 8:20:37 PM
Does it? On November 13, 2020, Gene
GNBTQ Generex Biotechnology Corp.
12/17/2020 4:18:26 PM
Well, now we know the answer to my (4)
GNBTQ Generex Biotechnology Corp.
12/16/2020 6:14:47 PM
Yea but it also says they want a jo (1)
GNBTQ Generex Biotechnology Corp.
12/16/2020 4:09:55 PM
Yes, AE was wholly owned, not anymo (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Hyundai's Supernal Faces Leadership Changes, Future Uncertain
  • Larry Ellison: From College Dropout to Tech Titan
  • Gold Producers Tackle Emissions with Mixed Results in ESG Metrics
  • China's Potential Ban on Flush Door Handles in Cars
  • Market Insights: Top 10 Large Cap Stocks Facing Declines
  • Crypto Landscape Shifts: Ethereum ETFs Surge Amid Market Changes
  • Investigating PACS Group, Inc.: Shareholder Concerns Addressed
  • Pomerantz Law Firm Launches Investigation on Freeport-McMoRan
  • Quanex Building Products Faces Potential Investor Claims Today
  • Geely Automobile Holdings: Investor Concerns and Legal Steps
  • MarineMax, Inc. Investors: Key Insights and Updates for HZO
  • Matrix Service Company Faces Scrutiny Over Investor Claims
  • Pomerantz Law Firm Investigates Potential Securities Fraud by BellRing Brands
  • Bumble Inc. Faces Legal Scrutiny Over Potential Securities Violations
  • Pomerantz Law Firm Launches Investigation into Agilon Health
  • Pomerantz Law Firm Reviews Securities Claims Against Synopsys
  • Investor Investigation: Duolingo, Inc. Faces Claims and Trends
  • Insperity, Inc. Under Investigation for Possible Securities Fraud
  • Class Action Filed Against Dow Inc. by Pomerantz Law Firm
  • Concerns Rise as Pomerantz Law Firm Investigates Fluor Corp
  • Big Week for Large-Cap Stocks: Top Gainers You Can't Miss
  • Celebrating Everlight Solar: Madison's Top Choice in 2025
  • Invest in Capricor Therapeutics: Upcoming Class Action Deadline
  • California's AI Safety Bill Awaits Final Authoritative Approval
  • Elon Musk Presses Microsoft CEO on Activision Blizzard Remarks
  • Optimove Leads with Innovative Solutions for iGaming Growth
  • Exploring America’s Race to Artificial Superintelligence
  • How Buck Sexton Highlights Leadership in the AI Arms Race
  • Elevate Your Skills: Join PayrollOrg’s Leadership Conference
  • Celebrating Fashion: A Night of Style With Calvin Klein
  • Recent Crypto Trends: Silver Surges and Dogecoin's Rise
  • Political Charges and Market Movements: A Crypto Perspective
  • Fangzhou's Innovative AI Technology Revolutionizes Health Care
  • Investigation into Lantheus Holdings by Securities Law Firm
  • Monopar Therapeutics Reveals Promising ALXN1840 Findings
  • Weekly Highlights in Mobility: EV Sales Surge and Uber Lawsuit
  • HKUST Strengthens Global Innovation Ties with Sweden
  • Monopar Showcasing Promising Long-Term Data for ALXN1840
  • Market Insights: iPhone 17 Unveiling and AI Growth Trends
  • Explore Dubai Effortlessly: Thrivestate's Unique Program
  • Court Deadline Approaches for RxSight Investors Amid Revelations
  • Lineage, Inc. Faces Securities Lawsuit: Key Details and Actions
  • Investors of Charter Communications Urged to Take Action Now
  • Experience Dubai Before Investing: Thrivestate's New Program
  • XRP Tundra Launches Innovative Cryo Vaults for Staking Rewards
  • Tech Giants Face Criticism while Innovating Health Solutions
  • Subsea7 Secures Major Offshore Project in Saudi Arabia
  • Aleo Network Foundation Expands Access through Binance Alpha
  • Exciting Housing Initiative Announced by Minister Lightbound
  • Penske Media Challenges Google Over AI Content Practices
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site